Virtual compound screening in drug discovery

Future Medicinal Chemistry

Volumn 4, Issue 5, 2012, Pages 593-602

  Stumpfe, Dagmar ^a   Ripphausen, Peter ^a   Bajorath, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

DRUG DEVELOPMENT; DRUG IDENTIFICATION; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL; REVIEW;

BINDING SITES; COMBINATORIAL CHEMISTRY TECHNIQUES; COMPUTER SIMULATION; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HIGH-THROUGHPUT SCREENING ASSAYS; LIGANDS; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84859450331     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.12.19     Document Type: Review

References (33)

1. Horvath D. A virtual screening approach applied to the search for trypanothione reductase inhibitors. J. Med. Chem. 40(15), 2412-2423 (1997). (Pubitemid 27342575)
2. Walters WP, Stahl MT, Murcko MA. Virtual screening - an overview. Drug Discov. Today 3(4), 160-178 (1998). (Pubitemid 128715971)
3. Langer T, Hoffmann RD. Virtual screening: An effective tool for lead structure discovery. Curr. Pharm. Design 7(7), 509-527 (2001). (Pubitemid 32422003)
4. Xu H, Agrafiotis DK. Retrospect and prospect of virtual screening in drug discovery. Curr. Top. Med. Chem. 2(12), 1305-1320 (2002).
5. Seifert MHJ, Wolf K, Vitt D. Virtual high-Throughput in silico screening. Drug Dicov. Today Biosilico. 1(4), 143-149 (2003). (Pubitemid 40416767)
6. Geppert H, Vogt M, Bajorath J. Current trends in ligand-based virtual screening: Molecular representations, data mining methods, new application areas, and performance evaluation. J. Chem. Inf. Model. 50(2), 205-216 (2010).
7. Ripphausen P, Nisius B, Bajorath J. State-of-The-art in ligand-based virtual screening. Drug Discov. Today 16(9-10), 372-376 (2011).
8. Lyne P. Structure-based virtual screening: An overview. Drug Discov. Today 7(20), 1047-1055 (2002).
9. Villoutreix BO, Eudes R, Miteva MA. Structure-based virtual ligand screening: Recent success stories. Comb. Chem. High Throughput Screen. 12(10), 1000-1016 (2009).
10. Polgar T, Keseru GM. Structure-based virtual screening. Front. Drug Des. Discov. 3(1), 477-502 (2007).
11. Yang S-Y. Pharmacophore modeling and applications in drug discovery: Challenges and recent advances. Drug Discov. Today 15(1-12), 444-450 (2010).
12. Kim K-H, Kim ND, Seong B-L. Pharmacophore-based virtual screening: A review of recent applications. Expert Opin. Drug Discov. 5(3), 205-222 (2010).
13. Muegge I. Synergies of virtual screening approaches. Mini Rev. Med. Chem. 8(9), 927-933 (2008).
14. Ripphausen P, Nisius B, Peltason L, Bajorath J. Quo vadis, virtual screening? A comprehensive survey of prospective applications. J. Med. Chem. 53(24), 8461-8467 (2010).
15. Ripphausen P, Stumpfe D, Bajorath J. Analysis of structure-based virtual screening studies and characterization of identified active compounds. Future Med. Chem. 4(5), 601-613 (2012).
16. Schneider G, Neidhart W, Giller T, Schmid, G. "Scaffold- hopping" by topological pharmacophore search: A contribution to virtual screening. Angew. Chem. Int. Ed. 38(19) 2894-2896 (1999). (Pubitemid 29479958)
17. Hu Y, Stumpfe D, Bajorath J. Lessons learned from molecular scaffold analysis. J. Chem. Inf. Model. 51(8), 1742-1753 (2011).
18. Brown N, Jacoby E. On scaffolds and hopping in medicinal chemistry. Mini Rev. Med. Chem. 6(11), 1217-1229 (2006). (Pubitemid 44697101)
19. Li R, Stumpfe D, Vogt M, Geppert H, Bajorath J. Development of a method to consistently quantify the structural distance between scaffolds and to assess scaffold hopping potential. J. Chem. Inf. Model. 51(10), 2507-2514 (2011).
20. Ripphausen P, Wassermann AM, Bajorath J. Reprovis-DB: A benchmark system for ligand-based virtual screening derived from reproducible prospective applications. J. Chem. Inf. Model. 51(10), 2467-2473 (2011).
21. Vogt M, Stumpfe D, Geppert H, Bajorath J. Scaffold hopping using two-dimensional fingerprints: True potential, black magic, or a hopeless endeavor? Guidelines for virtual screening. J. Med. Chem. 53(15), 5707-5715 (2010).
22. Gardiner EJ, Holliday JD, O'Dowd C, Willett P. Effectiveness of 2D fingerprints for scaffold hopping. Fut. Med. Chem. 3(4), 405-414 (2011).
23. Stumpfe D, Bajorath J. Applied virtual screening: Strategies, recommendations, and caveats. In: Methods and Principles in Medicinal Chemistry. Virtual Screening. Principles, Challenges, and Practical Guidelines. C Sotriffer (Ed.). Wiley-VCH, Weinheim, Germany, 73-103 (2011).
24. Bologa CG, Revankar CM, Young SM et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2(4), 207-212 (2006).
25. Al-Sha'er MA, Taha MO. Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90a inhibitors. J. Chem. Inf. Model. 50(9), 1706-1723 (2010).
26. Katritch V, Jaakola V-P,Lane JR et al. Structure-based discovery of novel chemotypes for adenosine A2A receptor antagonists. J. Med. Chem. 53(4), 1799-1809 (2010).
27. Stumpfe D, Bill A, Novak N et al. Targeting multifunctional proteins by virtual screening: Structurally diverse cytohesin inhibitors with differentiated biological functions. ACS Chem. Biol. 5(9), 839-849 (2010).
28. Bill A, Blockus H, Stumpfe D et al. A homogeneous fluorescence resonance energy transfer system for monitoring the activation of a protein switch in real time. J. Am. Chem. Soc. 133(21), 8372-8379 (2011).
29. Bajorath J. Integration of virtual and high-Throughput screening. Nat. Rev. Drug Discov. 1(11), 882-894 (2002). (Pubitemid 37361583)
30. Polgar T, Keseru GM. Integration of virtual and high throughput screening in lead discovery settings. Comb. Chem. High Throughput Screen. 14(10), 889-897 (2011).
31. Engels MFM, Venkatarangan, P. Smart screening: Approaches to efficient HTS. Curr. Opin. Drug Discov. Develop. 4(3), 275-283 (2001). (Pubitemid 32499896)
32. Schopfer U, Engeloch C, Stanek J et al. The Novartis compound archive - from concept to reality. Comb. Chem. High Throughput Screen. 8(6) 513-519 (2005). (Pubitemid 41242955)
33. Crismann TJ, Jenkins JL, Parker CN et al. "Plate Cherry Picking": A novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection. J. Biomol. Screen. 12(3), 320-327 (2007). (Pubitemid 46514676)